nodes	percent_of_prediction	percent_of_DWPC	metapath
Glimepiride—KCNJ1—collecting duct of renal tubule—kidney cancer	0.169	0.505	CbGeAlD
Glimepiride—KCNJ1—nephron—kidney cancer	0.0752	0.225	CbGeAlD
Glimepiride—CYP2C9—Capecitabine—kidney cancer	0.0187	0.458	CbGbCtD
Glimepiride—KCNJ1—nephron tubule—kidney cancer	0.0162	0.0485	CbGeAlD
Glimepiride—CYP2C9—urine—kidney cancer	0.0151	0.045	CbGeAlD
Glimepiride—KCNJ1—renal system—kidney cancer	0.0148	0.0441	CbGeAlD
Glimepiride—KCNJ1—kidney—kidney cancer	0.0143	0.0426	CbGeAlD
Glimepiride—KCNJ1—cortex of kidney—kidney cancer	0.0139	0.0415	CbGeAlD
Glimepiride—CYP2C9—Paclitaxel—kidney cancer	0.0117	0.287	CbGbCtD
Glimepiride—CYP2C9—Sorafenib—kidney cancer	0.0104	0.255	CbGbCtD
Glimepiride—ABCC8—renal system—kidney cancer	0.00824	0.0246	CbGeAlD
Glimepiride—ABCC8—kidney—kidney cancer	0.00797	0.0238	CbGeAlD
Glimepiride—Gliclazide—VEGFA—kidney cancer	0.00503	0.573	CrCbGaD
Glimepiride—Chlorpropamide—PTGS1—kidney cancer	0.00207	0.235	CrCbGaD
Glimepiride—Chlorpropamide—ABCB1—kidney cancer	0.001	0.114	CrCbGaD
Glimepiride—Glyburide—ABCB1—kidney cancer	0.000678	0.0772	CrCbGaD
Glimepiride—Hyperhidrosis—Vincristine—kidney cancer	0.000666	0.00109	CcSEcCtD
Glimepiride—Pruritus—Erlotinib—kidney cancer	0.000666	0.00109	CcSEcCtD
Glimepiride—Fatigue—Dactinomycin—kidney cancer	0.000665	0.00109	CcSEcCtD
Glimepiride—Tension—Paclitaxel—kidney cancer	0.000658	0.00108	CcSEcCtD
Glimepiride—Agranulocytosis—Capecitabine—kidney cancer	0.000657	0.00107	CcSEcCtD
Glimepiride—Anorexia—Vincristine—kidney cancer	0.000657	0.00107	CcSEcCtD
Glimepiride—Hepatic failure—Doxorubicin—kidney cancer	0.000655	0.00107	CcSEcCtD
Glimepiride—Anaphylactic shock—Gemcitabine—kidney cancer	0.000654	0.00107	CcSEcCtD
Glimepiride—Nervousness—Paclitaxel—kidney cancer	0.000651	0.00106	CcSEcCtD
Glimepiride—Dizziness—Vinblastine—kidney cancer	0.000647	0.00106	CcSEcCtD
Glimepiride—Dizziness—Everolimus—kidney cancer	0.000645	0.00105	CcSEcCtD
Glimepiride—Abdominal pain—Sunitinib—kidney cancer	0.000644	0.00105	CcSEcCtD
Glimepiride—Diarrhoea—Erlotinib—kidney cancer	0.000644	0.00105	CcSEcCtD
Glimepiride—Hypotension—Vincristine—kidney cancer	0.000644	0.00105	CcSEcCtD
Glimepiride—Bradycardia—Capecitabine—kidney cancer	0.000643	0.00105	CcSEcCtD
Glimepiride—Thrombocytopenia—Gemcitabine—kidney cancer	0.00064	0.00105	CcSEcCtD
Glimepiride—Feeling abnormal—Dactinomycin—kidney cancer	0.000635	0.00104	CcSEcCtD
Glimepiride—Hepatitis—Capecitabine—kidney cancer	0.000632	0.00103	CcSEcCtD
Glimepiride—Vision blurred—Paclitaxel—kidney cancer	0.000632	0.00103	CcSEcCtD
Glimepiride—Hyperhidrosis—Gemcitabine—kidney cancer	0.000632	0.00103	CcSEcCtD
Glimepiride—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000631	0.00103	CcSEcCtD
Glimepiride—Hot flush—Doxorubicin—kidney cancer	0.00063	0.00103	CcSEcCtD
Glimepiride—Tremor—Paclitaxel—kidney cancer	0.000628	0.00103	CcSEcCtD
Glimepiride—Increased appetite—Doxorubicin—kidney cancer	0.000627	0.00102	CcSEcCtD
Glimepiride—Menopausal symptoms—Doxorubicin—kidney cancer	0.000624	0.00102	CcSEcCtD
Glimepiride—Hypersensitivity—Sorafenib—kidney cancer	0.000624	0.00102	CcSEcCtD
Glimepiride—Insomnia—Vincristine—kidney cancer	0.000623	0.00102	CcSEcCtD
Glimepiride—Anorexia—Gemcitabine—kidney cancer	0.000623	0.00102	CcSEcCtD
Glimepiride—Vomiting—Vinblastine—kidney cancer	0.000622	0.00102	CcSEcCtD
Glimepiride—Dizziness—Erlotinib—kidney cancer	0.000622	0.00102	CcSEcCtD
Glimepiride—Vomiting—Everolimus—kidney cancer	0.00062	0.00101	CcSEcCtD
Glimepiride—Anaemia—Paclitaxel—kidney cancer	0.00062	0.00101	CcSEcCtD
Glimepiride—Paraesthesia—Vincristine—kidney cancer	0.000619	0.00101	CcSEcCtD
Glimepiride—Dermatitis bullous—Doxorubicin—kidney cancer	0.000616	0.00101	CcSEcCtD
Glimepiride—Agitation—Paclitaxel—kidney cancer	0.000616	0.00101	CcSEcCtD
Glimepiride—Rash—Everolimus—kidney cancer	0.000615	0.00101	CcSEcCtD
Glimepiride—Dermatitis—Everolimus—kidney cancer	0.000614	0.001	CcSEcCtD
Glimepiride—Headache—Vinblastine—kidney cancer	0.000613	0.001	CcSEcCtD
Glimepiride—Angioedema—Paclitaxel—kidney cancer	0.000613	0.001	CcSEcCtD
Glimepiride—Headache—Everolimus—kidney cancer	0.000611	0.000999	CcSEcCtD
Glimepiride—Hypotension—Gemcitabine—kidney cancer	0.000611	0.000999	CcSEcCtD
Glimepiride—Abdominal pain—Dactinomycin—kidney cancer	0.00061	0.000997	CcSEcCtD
Glimepiride—Visual impairment—Capecitabine—kidney cancer	0.000609	0.000996	CcSEcCtD
Glimepiride—Asthenia—Sorafenib—kidney cancer	0.000607	0.000993	CcSEcCtD
Glimepiride—Hypoglycaemia—Doxorubicin—kidney cancer	0.000603	0.000987	CcSEcCtD
Glimepiride—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000601	0.000983	CcSEcCtD
Glimepiride—Leukopenia—Paclitaxel—kidney cancer	0.0006	0.000981	CcSEcCtD
Glimepiride—Hypersensitivity—Sunitinib—kidney cancer	0.0006	0.000981	CcSEcCtD
Glimepiride—Decreased appetite—Vincristine—kidney cancer	0.000599	0.000979	CcSEcCtD
Glimepiride—Pruritus—Sorafenib—kidney cancer	0.000599	0.000979	CcSEcCtD
Glimepiride—Vomiting—Erlotinib—kidney cancer	0.000598	0.000978	CcSEcCtD
Glimepiride—Erythema multiforme—Capecitabine—kidney cancer	0.000598	0.000977	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Vincristine—kidney cancer	0.000595	0.000973	CcSEcCtD
Glimepiride—Fatigue—Vincristine—kidney cancer	0.000594	0.000971	CcSEcCtD
Glimepiride—Rash—Erlotinib—kidney cancer	0.000593	0.00097	CcSEcCtD
Glimepiride—Dermatitis—Erlotinib—kidney cancer	0.000593	0.000969	CcSEcCtD
Glimepiride—Palpitations—Paclitaxel—kidney cancer	0.000593	0.000969	CcSEcCtD
Glimepiride—Hyponatraemia—Doxorubicin—kidney cancer	0.000591	0.000967	CcSEcCtD
Glimepiride—Insomnia—Gemcitabine—kidney cancer	0.000591	0.000967	CcSEcCtD
Glimepiride—Headache—Erlotinib—kidney cancer	0.000589	0.000964	CcSEcCtD
Glimepiride—Loss of consciousness—Paclitaxel—kidney cancer	0.000589	0.000964	CcSEcCtD
Glimepiride—Pain in extremity—Doxorubicin—kidney cancer	0.000589	0.000963	CcSEcCtD
Glimepiride—Paraesthesia—Gemcitabine—kidney cancer	0.000587	0.00096	CcSEcCtD
Glimepiride—Asthenia—Sunitinib—kidney cancer	0.000584	0.000956	CcSEcCtD
Glimepiride—Dyspnoea—Gemcitabine—kidney cancer	0.000583	0.000953	CcSEcCtD
Glimepiride—Nausea—Vinblastine—kidney cancer	0.000581	0.000951	CcSEcCtD
Glimepiride—Somnolence—Gemcitabine—kidney cancer	0.000581	0.00095	CcSEcCtD
Glimepiride—Convulsion—Paclitaxel—kidney cancer	0.000581	0.00095	CcSEcCtD
Glimepiride—Nausea—Everolimus—kidney cancer	0.000579	0.000947	CcSEcCtD
Glimepiride—Diarrhoea—Sorafenib—kidney cancer	0.000579	0.000947	CcSEcCtD
Glimepiride—Hypertension—Paclitaxel—kidney cancer	0.000579	0.000946	CcSEcCtD
Glimepiride—Pruritus—Sunitinib—kidney cancer	0.000576	0.000942	CcSEcCtD
Glimepiride—Anxiety—Paclitaxel—kidney cancer	0.000569	0.00093	CcSEcCtD
Glimepiride—Decreased appetite—Gemcitabine—kidney cancer	0.000568	0.000929	CcSEcCtD
Glimepiride—Hypersensitivity—Dactinomycin—kidney cancer	0.000568	0.000929	CcSEcCtD
Glimepiride—Arrhythmia—Capecitabine—kidney cancer	0.000565	0.000923	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000564	0.000923	CcSEcCtD
Glimepiride—Fatigue—Gemcitabine—kidney cancer	0.000563	0.000921	CcSEcCtD
Glimepiride—Gastrointestinal pain—Vincristine—kidney cancer	0.000563	0.000921	CcSEcCtD
Glimepiride—Dizziness—Sorafenib—kidney cancer	0.00056	0.000915	CcSEcCtD
Glimepiride—Nausea—Erlotinib—kidney cancer	0.000559	0.000914	CcSEcCtD
Glimepiride—Dry mouth—Paclitaxel—kidney cancer	0.000558	0.000913	CcSEcCtD
Glimepiride—Diarrhoea—Sunitinib—kidney cancer	0.000557	0.000911	CcSEcCtD
Glimepiride—Asthenia—Dactinomycin—kidney cancer	0.000553	0.000905	CcSEcCtD
Glimepiride—Confusional state—Paclitaxel—kidney cancer	0.000552	0.000902	CcSEcCtD
Glimepiride—Malnutrition—Capecitabine—kidney cancer	0.00055	0.0009	CcSEcCtD
Glimepiride—Erythema—Capecitabine—kidney cancer	0.00055	0.0009	CcSEcCtD
Glimepiride—Anaphylactic shock—Paclitaxel—kidney cancer	0.000547	0.000895	CcSEcCtD
Glimepiride—Abdominal pain—Vincristine—kidney cancer	0.000545	0.00089	CcSEcCtD
Glimepiride—Dizziness—Sunitinib—kidney cancer	0.000539	0.000881	CcSEcCtD
Glimepiride—Feeling abnormal—Gemcitabine—kidney cancer	0.000539	0.000881	CcSEcCtD
Glimepiride—Shock—Paclitaxel—kidney cancer	0.000538	0.00088	CcSEcCtD
Glimepiride—Vomiting—Sorafenib—kidney cancer	0.000538	0.00088	CcSEcCtD
Glimepiride—Thrombocytopenia—Paclitaxel—kidney cancer	0.000536	0.000876	CcSEcCtD
Glimepiride—Tachycardia—Paclitaxel—kidney cancer	0.000534	0.000873	CcSEcCtD
Glimepiride—Rash—Sorafenib—kidney cancer	0.000534	0.000873	CcSEcCtD
Glimepiride—Dermatitis—Sorafenib—kidney cancer	0.000533	0.000872	CcSEcCtD
Glimepiride—Headache—Sorafenib—kidney cancer	0.00053	0.000867	CcSEcCtD
Glimepiride—Hyperhidrosis—Paclitaxel—kidney cancer	0.000529	0.000865	CcSEcCtD
Glimepiride—Diarrhoea—Dactinomycin—kidney cancer	0.000528	0.000863	CcSEcCtD
Glimepiride—Anorexia—Paclitaxel—kidney cancer	0.000522	0.000853	CcSEcCtD
Glimepiride—Alanine aminotransferase increased—Doxorubicin—kidney cancer	0.000519	0.000849	CcSEcCtD
Glimepiride—Vision blurred—Capecitabine—kidney cancer	0.000519	0.000848	CcSEcCtD
Glimepiride—Vomiting—Sunitinib—kidney cancer	0.000518	0.000847	CcSEcCtD
Glimepiride—Tremor—Capecitabine—kidney cancer	0.000516	0.000843	CcSEcCtD
Glimepiride—Rash—Sunitinib—kidney cancer	0.000514	0.00084	CcSEcCtD
Glimepiride—Dermatitis—Sunitinib—kidney cancer	0.000513	0.000839	CcSEcCtD
Glimepiride—Abdominal distension—Doxorubicin—kidney cancer	0.000512	0.000838	CcSEcCtD
Glimepiride—Hypotension—Paclitaxel—kidney cancer	0.000511	0.000836	CcSEcCtD
Glimepiride—Headache—Sunitinib—kidney cancer	0.00051	0.000834	CcSEcCtD
Glimepiride—Influenza—Doxorubicin—kidney cancer	0.000509	0.000832	CcSEcCtD
Glimepiride—Anaemia—Capecitabine—kidney cancer	0.000509	0.000832	CcSEcCtD
Glimepiride—Hypersensitivity—Vincristine—kidney cancer	0.000508	0.00083	CcSEcCtD
Glimepiride—Eosinophilia—Doxorubicin—kidney cancer	0.000504	0.000824	CcSEcCtD
Glimepiride—Nausea—Sorafenib—kidney cancer	0.000503	0.000822	CcSEcCtD
Glimepiride—Angina pectoris—Doxorubicin—kidney cancer	0.000496	0.000811	CcSEcCtD
Glimepiride—Insomnia—Paclitaxel—kidney cancer	0.000495	0.000809	CcSEcCtD
Glimepiride—Asthenia—Vincristine—kidney cancer	0.000494	0.000808	CcSEcCtD
Glimepiride—Leukopenia—Capecitabine—kidney cancer	0.000493	0.000805	CcSEcCtD
Glimepiride—Paraesthesia—Paclitaxel—kidney cancer	0.000491	0.000803	CcSEcCtD
Glimepiride—Vomiting—Dactinomycin—kidney cancer	0.00049	0.000802	CcSEcCtD
Glimepiride—Dyspnoea—Paclitaxel—kidney cancer	0.000488	0.000798	CcSEcCtD
Glimepiride—Somnolence—Paclitaxel—kidney cancer	0.000486	0.000795	CcSEcCtD
Glimepiride—Palpitations—Capecitabine—kidney cancer	0.000486	0.000795	CcSEcCtD
Glimepiride—Rash—Dactinomycin—kidney cancer	0.000486	0.000795	CcSEcCtD
Glimepiride—Nausea—Sunitinib—kidney cancer	0.000484	0.000791	CcSEcCtD
Glimepiride—Loss of consciousness—Capecitabine—kidney cancer	0.000484	0.000791	CcSEcCtD
Glimepiride—Pancytopenia—Doxorubicin—kidney cancer	0.000483	0.00079	CcSEcCtD
Glimepiride—Dyspepsia—Paclitaxel—kidney cancer	0.000482	0.000788	CcSEcCtD
Glimepiride—Decreased appetite—Paclitaxel—kidney cancer	0.000476	0.000778	CcSEcCtD
Glimepiride—Hypertension—Capecitabine—kidney cancer	0.000475	0.000777	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000472	0.000772	CcSEcCtD
Glimepiride—Fatigue—Paclitaxel—kidney cancer	0.000472	0.000771	CcSEcCtD
Glimepiride—Diarrhoea—Vincristine—kidney cancer	0.000471	0.000771	CcSEcCtD
Glimepiride—Pollakiuria—Doxorubicin—kidney cancer	0.00047	0.000769	CcSEcCtD
Glimepiride—Asthenia—Gemcitabine—kidney cancer	0.000469	0.000767	CcSEcCtD
Glimepiride—Anxiety—Capecitabine—kidney cancer	0.000467	0.000763	CcSEcCtD
Glimepiride—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000465	0.00076	CcSEcCtD
Glimepiride—Weight increased—Doxorubicin—kidney cancer	0.000463	0.000757	CcSEcCtD
Glimepiride—Pruritus—Gemcitabine—kidney cancer	0.000462	0.000756	CcSEcCtD
Glimepiride—Dry mouth—Capecitabine—kidney cancer	0.000458	0.000749	CcSEcCtD
Glimepiride—Nausea—Dactinomycin—kidney cancer	0.000458	0.000749	CcSEcCtD
Glimepiride—Dizziness—Vincristine—kidney cancer	0.000456	0.000745	CcSEcCtD
Glimepiride—Drowsiness—Doxorubicin—kidney cancer	0.000454	0.000742	CcSEcCtD
Glimepiride—Confusional state—Capecitabine—kidney cancer	0.000453	0.00074	CcSEcCtD
Glimepiride—Feeling abnormal—Paclitaxel—kidney cancer	0.000451	0.000737	CcSEcCtD
Glimepiride—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	0.00045	0.000736	CcSEcCtD
Glimepiride—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000447	0.000732	CcSEcCtD
Glimepiride—Diarrhoea—Gemcitabine—kidney cancer	0.000447	0.000731	CcSEcCtD
Glimepiride—Jaundice—Doxorubicin—kidney cancer	0.000442	0.000723	CcSEcCtD
Glimepiride—Shock—Capecitabine—kidney cancer	0.000442	0.000722	CcSEcCtD
Glimepiride—Thrombocytopenia—Capecitabine—kidney cancer	0.00044	0.000719	CcSEcCtD
Glimepiride—Tachycardia—Capecitabine—kidney cancer	0.000438	0.000717	CcSEcCtD
Glimepiride—Vomiting—Vincristine—kidney cancer	0.000438	0.000716	CcSEcCtD
Glimepiride—Sweating—Doxorubicin—kidney cancer	0.000435	0.000711	CcSEcCtD
Glimepiride—Urticaria—Paclitaxel—kidney cancer	0.000435	0.000711	CcSEcCtD
Glimepiride—Rash—Vincristine—kidney cancer	0.000434	0.00071	CcSEcCtD
Glimepiride—Hyperhidrosis—Capecitabine—kidney cancer	0.000434	0.00071	CcSEcCtD
Glimepiride—Dermatitis—Vincristine—kidney cancer	0.000434	0.00071	CcSEcCtD
Glimepiride—Abdominal pain—Paclitaxel—kidney cancer	0.000433	0.000707	CcSEcCtD
Glimepiride—Headache—Vincristine—kidney cancer	0.000432	0.000706	CcSEcCtD
Glimepiride—Anorexia—Capecitabine—kidney cancer	0.000428	0.0007	CcSEcCtD
Glimepiride—Agranulocytosis—Doxorubicin—kidney cancer	0.000424	0.000693	CcSEcCtD
Glimepiride—Hypotension—Capecitabine—kidney cancer	0.00042	0.000686	CcSEcCtD
Glimepiride—Vomiting—Gemcitabine—kidney cancer	0.000416	0.000679	CcSEcCtD
Glimepiride—Bradycardia—Doxorubicin—kidney cancer	0.000415	0.000678	CcSEcCtD
Glimepiride—Rash—Gemcitabine—kidney cancer	0.000412	0.000674	CcSEcCtD
Glimepiride—Dermatitis—Gemcitabine—kidney cancer	0.000412	0.000673	CcSEcCtD
Glimepiride—Headache—Gemcitabine—kidney cancer	0.000409	0.000669	CcSEcCtD
Glimepiride—Nausea—Vincristine—kidney cancer	0.000409	0.000669	CcSEcCtD
Glimepiride—Hepatitis—Doxorubicin—kidney cancer	0.000407	0.000666	CcSEcCtD
Glimepiride—Insomnia—Capecitabine—kidney cancer	0.000406	0.000664	CcSEcCtD
Glimepiride—Paraesthesia—Capecitabine—kidney cancer	0.000403	0.000659	CcSEcCtD
Glimepiride—Hypersensitivity—Paclitaxel—kidney cancer	0.000403	0.000659	CcSEcCtD
Glimepiride—Dyspnoea—Capecitabine—kidney cancer	0.0004	0.000655	CcSEcCtD
Glimepiride—Dyspepsia—Capecitabine—kidney cancer	0.000395	0.000646	CcSEcCtD
Glimepiride—Visual impairment—Doxorubicin—kidney cancer	0.000393	0.000642	CcSEcCtD
Glimepiride—Asthenia—Paclitaxel—kidney cancer	0.000393	0.000642	CcSEcCtD
Glimepiride—Decreased appetite—Capecitabine—kidney cancer	0.00039	0.000638	CcSEcCtD
Glimepiride—Nausea—Gemcitabine—kidney cancer	0.000388	0.000635	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000388	0.000634	CcSEcCtD
Glimepiride—Fatigue—Capecitabine—kidney cancer	0.000387	0.000633	CcSEcCtD
Glimepiride—Pruritus—Paclitaxel—kidney cancer	0.000387	0.000633	CcSEcCtD
Glimepiride—Erythema multiforme—Doxorubicin—kidney cancer	0.000385	0.00063	CcSEcCtD
Glimepiride—Diarrhoea—Paclitaxel—kidney cancer	0.000374	0.000612	CcSEcCtD
Glimepiride—Feeling abnormal—Capecitabine—kidney cancer	0.00037	0.000605	CcSEcCtD
Glimepiride—Gastrointestinal pain—Capecitabine—kidney cancer	0.000367	0.0006	CcSEcCtD
Glimepiride—Arrhythmia—Doxorubicin—kidney cancer	0.000364	0.000595	CcSEcCtD
Glimepiride—Dizziness—Paclitaxel—kidney cancer	0.000362	0.000592	CcSEcCtD
Glimepiride—Urticaria—Capecitabine—kidney cancer	0.000357	0.000583	CcSEcCtD
Glimepiride—Abdominal pain—Capecitabine—kidney cancer	0.000355	0.00058	CcSEcCtD
Glimepiride—Malnutrition—Doxorubicin—kidney cancer	0.000355	0.00058	CcSEcCtD
Glimepiride—Erythema—Doxorubicin—kidney cancer	0.000355	0.00058	CcSEcCtD
Glimepiride—Tension—Doxorubicin—kidney cancer	0.000348	0.000569	CcSEcCtD
Glimepiride—Vomiting—Paclitaxel—kidney cancer	0.000348	0.000569	CcSEcCtD
Glimepiride—Rash—Paclitaxel—kidney cancer	0.000345	0.000564	CcSEcCtD
Glimepiride—Dermatitis—Paclitaxel—kidney cancer	0.000345	0.000564	CcSEcCtD
Glimepiride—Nervousness—Doxorubicin—kidney cancer	0.000344	0.000563	CcSEcCtD
Glimepiride—Headache—Paclitaxel—kidney cancer	0.000343	0.000561	CcSEcCtD
Glimepiride—Vision blurred—Doxorubicin—kidney cancer	0.000334	0.000547	CcSEcCtD
Glimepiride—Hypersensitivity—Capecitabine—kidney cancer	0.000331	0.000541	CcSEcCtD
Glimepiride—Anaemia—Doxorubicin—kidney cancer	0.000328	0.000536	CcSEcCtD
Glimepiride—Agitation—Doxorubicin—kidney cancer	0.000326	0.000533	CcSEcCtD
Glimepiride—Nausea—Paclitaxel—kidney cancer	0.000325	0.000531	CcSEcCtD
Glimepiride—Asthenia—Capecitabine—kidney cancer	0.000322	0.000527	CcSEcCtD
Glimepiride—Pruritus—Capecitabine—kidney cancer	0.000318	0.000519	CcSEcCtD
Glimepiride—Leukopenia—Doxorubicin—kidney cancer	0.000317	0.000519	CcSEcCtD
Glimepiride—Palpitations—Doxorubicin—kidney cancer	0.000313	0.000512	CcSEcCtD
Glimepiride—Loss of consciousness—Doxorubicin—kidney cancer	0.000312	0.00051	CcSEcCtD
Glimepiride—Convulsion—Doxorubicin—kidney cancer	0.000307	0.000502	CcSEcCtD
Glimepiride—Diarrhoea—Capecitabine—kidney cancer	0.000307	0.000502	CcSEcCtD
Glimepiride—Hypertension—Doxorubicin—kidney cancer	0.000306	0.000501	CcSEcCtD
Glimepiride—Anxiety—Doxorubicin—kidney cancer	0.000301	0.000492	CcSEcCtD
Glimepiride—Dizziness—Capecitabine—kidney cancer	0.000297	0.000486	CcSEcCtD
Glimepiride—Dry mouth—Doxorubicin—kidney cancer	0.000295	0.000483	CcSEcCtD
Glimepiride—Confusional state—Doxorubicin—kidney cancer	0.000292	0.000477	CcSEcCtD
Glimepiride—Anaphylactic shock—Doxorubicin—kidney cancer	0.000289	0.000473	CcSEcCtD
Glimepiride—Vomiting—Capecitabine—kidney cancer	0.000286	0.000467	CcSEcCtD
Glimepiride—Shock—Doxorubicin—kidney cancer	0.000285	0.000466	CcSEcCtD
Glimepiride—Thrombocytopenia—Doxorubicin—kidney cancer	0.000283	0.000463	CcSEcCtD
Glimepiride—Rash—Capecitabine—kidney cancer	0.000283	0.000463	CcSEcCtD
Glimepiride—Dermatitis—Capecitabine—kidney cancer	0.000283	0.000463	CcSEcCtD
Glimepiride—Tachycardia—Doxorubicin—kidney cancer	0.000283	0.000462	CcSEcCtD
Glimepiride—Headache—Capecitabine—kidney cancer	0.000281	0.00046	CcSEcCtD
Glimepiride—Hyperhidrosis—Doxorubicin—kidney cancer	0.00028	0.000458	CcSEcCtD
Glimepiride—Anorexia—Doxorubicin—kidney cancer	0.000276	0.000451	CcSEcCtD
Glimepiride—Hypotension—Doxorubicin—kidney cancer	0.00027	0.000442	CcSEcCtD
Glimepiride—Nausea—Capecitabine—kidney cancer	0.000267	0.000436	CcSEcCtD
Glimepiride—Insomnia—Doxorubicin—kidney cancer	0.000262	0.000428	CcSEcCtD
Glimepiride—Paraesthesia—Doxorubicin—kidney cancer	0.00026	0.000425	CcSEcCtD
Glimepiride—Dyspnoea—Doxorubicin—kidney cancer	0.000258	0.000422	CcSEcCtD
Glimepiride—Somnolence—Doxorubicin—kidney cancer	0.000257	0.000421	CcSEcCtD
Glimepiride—Dyspepsia—Doxorubicin—kidney cancer	0.000255	0.000417	CcSEcCtD
Glimepiride—ABCC8—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.000253	0.0588	CbGpPWpGaD
Glimepiride—Decreased appetite—Doxorubicin—kidney cancer	0.000252	0.000411	CcSEcCtD
Glimepiride—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00025	0.000409	CcSEcCtD
Glimepiride—Fatigue—Doxorubicin—kidney cancer	0.00025	0.000408	CcSEcCtD
Glimepiride—KCNJ11—FOXA2 and FOXA3 transcription factor networks—HNF1A—kidney cancer	0.000246	0.0571	CbGpPWpGaD
Glimepiride—Feeling abnormal—Doxorubicin—kidney cancer	0.000239	0.00039	CcSEcCtD
Glimepiride—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000237	0.000387	CcSEcCtD
Glimepiride—Urticaria—Doxorubicin—kidney cancer	0.00023	0.000376	CcSEcCtD
Glimepiride—Abdominal pain—Doxorubicin—kidney cancer	0.000229	0.000374	CcSEcCtD
Glimepiride—Hypersensitivity—Doxorubicin—kidney cancer	0.000213	0.000349	CcSEcCtD
Glimepiride—Asthenia—Doxorubicin—kidney cancer	0.000208	0.00034	CcSEcCtD
Glimepiride—KCNJ1—Potassium Channels—KCNMA1—kidney cancer	0.000206	0.0478	CbGpPWpGaD
Glimepiride—Pruritus—Doxorubicin—kidney cancer	0.000205	0.000335	CcSEcCtD
Glimepiride—Diarrhoea—Doxorubicin—kidney cancer	0.000198	0.000324	CcSEcCtD
Glimepiride—Dizziness—Doxorubicin—kidney cancer	0.000191	0.000313	CcSEcCtD
Glimepiride—Vomiting—Doxorubicin—kidney cancer	0.000184	0.000301	CcSEcCtD
Glimepiride—Rash—Doxorubicin—kidney cancer	0.000183	0.000298	CcSEcCtD
Glimepiride—Dermatitis—Doxorubicin—kidney cancer	0.000182	0.000298	CcSEcCtD
Glimepiride—Headache—Doxorubicin—kidney cancer	0.000181	0.000296	CcSEcCtD
Glimepiride—Nausea—Doxorubicin—kidney cancer	0.000172	0.000281	CcSEcCtD
Glimepiride—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—kidney cancer	0.000119	0.0275	CbGpPWpGaD
Glimepiride—ABCC8—ABC-family proteins mediated transport—ABCB1—kidney cancer	0.000115	0.0266	CbGpPWpGaD
Glimepiride—ABCC8—Potassium Channels—KCNMA1—kidney cancer	0.000105	0.0244	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—ITPR2—kidney cancer	0.000104	0.0242	CbGpPWpGaD
Glimepiride—KCNJ11—Potassium Channels—KCNMA1—kidney cancer	0.000102	0.0237	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—ITPR2—kidney cancer	0.000101	0.0235	CbGpPWpGaD
Glimepiride—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—kidney cancer	9.28e-05	0.0215	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—MTOR—kidney cancer	9.11e-05	0.0212	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—KCNMA1—kidney cancer	8.99e-05	0.0209	CbGpPWpGaD
Glimepiride—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—kidney cancer	8.45e-05	0.0196	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—ITPR2—kidney cancer	8.21e-05	0.0191	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—ITPR2—kidney cancer	7.96e-05	0.0185	CbGpPWpGaD
Glimepiride—ABCC8—Regulation of insulin secretion—SLC2A1—kidney cancer	7.91e-05	0.0184	CbGpPWpGaD
Glimepiride—KCNJ11—Regulation of insulin secretion—SLC2A1—kidney cancer	7.67e-05	0.0178	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—ACHE—kidney cancer	6.65e-05	0.0154	CbGpPWpGaD
Glimepiride—KCNJ11—Type II diabetes mellitus—MAPK1—kidney cancer	6.4e-05	0.0149	CbGpPWpGaD
Glimepiride—ABCC8—Integration of energy metabolism—SLC2A1—kidney cancer	6.22e-05	0.0144	CbGpPWpGaD
Glimepiride—KCNJ11—Integration of energy metabolism—SLC2A1—kidney cancer	6.03e-05	0.014	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—BCHE—kidney cancer	5.79e-05	0.0134	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RYR1—kidney cancer	5.19e-05	0.012	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—KCNMA1—kidney cancer	4.59e-05	0.0107	CbGpPWpGaD
Glimepiride—CYP2C9—Xenobiotics—CYP1A1—kidney cancer	4.46e-05	0.0104	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—KCNMA1—kidney cancer	4.46e-05	0.0103	CbGpPWpGaD
Glimepiride—CYP2C9—Tamoxifen metabolism—CYP1A1—kidney cancer	4.29e-05	0.00996	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	4.23e-05	0.00982	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—ACY1—kidney cancer	4.1e-05	0.00952	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—ACHE—kidney cancer	3.4e-05	0.00789	CbGpPWpGaD
Glimepiride—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	3.33e-05	0.00772	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS1—kidney cancer	3.33e-05	0.00772	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—ACHE—kidney cancer	3.3e-05	0.00765	CbGpPWpGaD
Glimepiride—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	3.17e-05	0.00736	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ANXA2—kidney cancer	2.98e-05	0.00692	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC5A3—kidney cancer	2.98e-05	0.00692	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ATP7B—kidney cancer	2.98e-05	0.00692	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BCHE—kidney cancer	2.96e-05	0.00687	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—BRAF—kidney cancer	2.96e-05	0.00686	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BCHE—kidney cancer	2.87e-05	0.00666	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACY1—kidney cancer	2.66e-05	0.00617	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACY1—kidney cancer	2.58e-05	0.00598	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—RAF1—kidney cancer	2.47e-05	0.00573	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	2.33e-05	0.00541	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PDHB—kidney cancer	2.26e-05	0.00525	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—ALDH1A1—kidney cancer	2.25e-05	0.00522	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PDHB—kidney cancer	2.19e-05	0.00509	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—CYP1A1—kidney cancer	2.14e-05	0.00497	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CCBL1—kidney cancer	2.12e-05	0.00493	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CCBL1—kidney cancer	2.06e-05	0.00478	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	1.85e-05	0.0043	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GLIPR1—kidney cancer	1.84e-05	0.00428	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PPAT—kidney cancer	1.84e-05	0.00428	CbGpPWpGaD
Glimepiride—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	1.83e-05	0.00424	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GLIPR1—kidney cancer	1.79e-05	0.00415	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PPAT—kidney cancer	1.79e-05	0.00415	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—APRT—kidney cancer	1.71e-05	0.00398	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—FH—kidney cancer	1.71e-05	0.00398	CbGpPWpGaD
Glimepiride—KCNJ1—Neuronal System—MAPK1—kidney cancer	1.69e-05	0.00393	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—APRT—kidney cancer	1.66e-05	0.00386	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—FH—kidney cancer	1.66e-05	0.00386	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GPC3—kidney cancer	1.61e-05	0.00374	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.57e-05	0.00365	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CA2—kidney cancer	1.57e-05	0.00364	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GPC3—kidney cancer	1.56e-05	0.00362	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALAD—kidney cancer	1.53e-05	0.00354	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CA2—kidney cancer	1.52e-05	0.00353	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.52e-05	0.00352	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—BRAF—kidney cancer	1.51e-05	0.00351	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	1.5e-05	0.00349	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ST3GAL2—kidney cancer	1.49e-05	0.00346	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALAD—kidney cancer	1.48e-05	0.00344	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—BRAF—kidney cancer	1.47e-05	0.0034	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ALDH1A1—kidney cancer	1.46e-05	0.00338	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ST3GAL2—kidney cancer	1.44e-05	0.00335	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ALDH1A1—kidney cancer	1.41e-05	0.00328	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PGK1—kidney cancer	1.4e-05	0.00324	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC5A3—kidney cancer	1.4e-05	0.00324	CbGpPWpGaD
Glimepiride—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	1.38e-05	0.00321	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—LDHB—kidney cancer	1.37e-05	0.00318	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PGK1—kidney cancer	1.35e-05	0.00314	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A3—kidney cancer	1.35e-05	0.00314	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—LDHB—kidney cancer	1.33e-05	0.00308	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTT1—kidney cancer	1.32e-05	0.00307	CbGpPWpGaD
Glimepiride—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	1.27e-05	0.00296	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—RAF1—kidney cancer	1.26e-05	0.00293	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—PTGS1—kidney cancer	1.24e-05	0.00287	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—RAF1—kidney cancer	1.22e-05	0.00284	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.2e-05	0.00278	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CA9—kidney cancer	1.19e-05	0.00276	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CA9—kidney cancer	1.15e-05	0.00267	CbGpPWpGaD
Glimepiride—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	1.12e-05	0.0026	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	1.09e-05	0.00253	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CRABP1—kidney cancer	1.01e-05	0.00234	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CRABP1—kidney cancer	9.79e-06	0.00227	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ITPR2—kidney cancer	9.38e-06	0.00218	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTP1—kidney cancer	9.15e-06	0.00213	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ITPR2—kidney cancer	9.1e-06	0.00211	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	9.03e-06	0.0021	CbGpPWpGaD
Glimepiride—ABCC8—Neuronal System—MAPK1—kidney cancer	8.65e-06	0.00201	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ACHE—kidney cancer	8.56e-06	0.00199	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTT1—kidney cancer	8.56e-06	0.00199	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—GSTM1—kidney cancer	8.41e-06	0.00195	CbGpPWpGaD
Glimepiride—KCNJ11—Neuronal System—MAPK1—kidney cancer	8.39e-06	0.00195	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ACHE—kidney cancer	8.3e-06	0.00193	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTT1—kidney cancer	8.3e-06	0.00193	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	8.3e-06	0.00193	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SCARB1—kidney cancer	8.1e-06	0.00188	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS1—kidney cancer	8.02e-06	0.00186	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	7.98e-06	0.00185	CbGpPWpGaD
Glimepiride—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	7.87e-06	0.00183	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PSMD7—kidney cancer	7.86e-06	0.00183	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SCARB1—kidney cancer	7.86e-06	0.00182	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS1—kidney cancer	7.78e-06	0.00181	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PSMD7—kidney cancer	7.63e-06	0.00177	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—BCHE—kidney cancer	7.46e-06	0.00173	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC5A5—kidney cancer	7.36e-06	0.00171	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—BCHE—kidney cancer	7.23e-06	0.00168	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC5A5—kidney cancer	7.14e-06	0.00166	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—SLC2A1—kidney cancer	7.11e-06	0.00165	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACY1—kidney cancer	7.02e-06	0.00163	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—SLC2A1—kidney cancer	6.9e-06	0.0016	CbGpPWpGaD
Glimepiride—ABCC8—Transmembrane transport of small molecules—RAF1—kidney cancer	6.78e-06	0.00157	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.98e-06	0.00139	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PDHB—kidney cancer	5.96e-06	0.00138	CbGpPWpGaD
Glimepiride—CYP2C9—Biological oxidations—POMC—kidney cancer	5.95e-06	0.00138	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTP1—kidney cancer	5.93e-06	0.00138	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTP1—kidney cancer	5.75e-06	0.00134	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—ABCB1—kidney cancer	5.62e-06	0.0013	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CCBL1—kidney cancer	5.61e-06	0.0013	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—GSTM1—kidney cancer	5.45e-06	0.00127	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—ABCB1—kidney cancer	5.45e-06	0.00126	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—GSTM1—kidney cancer	5.29e-06	0.00123	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—CYP1A1—kidney cancer	5.17e-06	0.0012	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	5.07e-06	0.00118	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—CYP1A1—kidney cancer	5.01e-06	0.00116	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.86e-06	0.00113	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PPAT—kidney cancer	4.86e-06	0.00113	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.8e-06	0.00111	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.75e-06	0.0011	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—APRT—kidney cancer	4.52e-06	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—FH—kidney cancer	4.52e-06	0.00105	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.42e-06	0.00103	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GPC3—kidney cancer	4.25e-06	0.000987	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA2—kidney cancer	4.13e-06	0.00096	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALAD—kidney cancer	4.03e-06	0.000935	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.93e-06	0.000913	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—POMC—kidney cancer	3.85e-06	0.000894	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.84e-06	0.000892	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—POMC—kidney cancer	3.74e-06	0.000867	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PGK1—kidney cancer	3.69e-06	0.000855	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.69e-06	0.000855	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—LDHB—kidney cancer	3.61e-06	0.000839	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CA9—kidney cancer	3.13e-06	0.000727	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTGS2—kidney cancer	3.07e-06	0.000713	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.06e-06	0.000711	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTGS2—kidney cancer	2.98e-06	0.000692	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PTEN—kidney cancer	2.68e-06	0.000622	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CRABP1—kidney cancer	2.66e-06	0.000618	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PTEN—kidney cancer	2.6e-06	0.000603	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ITPR2—kidney cancer	2.48e-06	0.000575	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.28e-06	0.00053	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ACHE—kidney cancer	2.26e-06	0.000524	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTT1—kidney cancer	2.26e-06	0.000524	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SCARB1—kidney cancer	2.14e-06	0.000496	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS1—kidney cancer	2.12e-06	0.000491	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PSMD7—kidney cancer	2.08e-06	0.000482	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—BCHE—kidney cancer	1.97e-06	0.000457	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.94e-06	0.000451	CbGpPWpGaD
Glimepiride—ABCC8—Metabolism—PIK3CA—kidney cancer	1.89e-06	0.000439	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.88e-06	0.000436	CbGpPWpGaD
Glimepiride—KCNJ11—Metabolism—PIK3CA—kidney cancer	1.83e-06	0.000426	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.82e-06	0.000423	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.59e-06	0.000369	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTP1—kidney cancer	1.57e-06	0.000363	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—ABCB1—kidney cancer	1.48e-06	0.000344	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—GSTM1—kidney cancer	1.44e-06	0.000334	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.36e-06	0.000317	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.12e-06	0.00026	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—POMC—kidney cancer	1.02e-06	0.000236	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTGS2—kidney cancer	8.11e-07	0.000188	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PTEN—kidney cancer	7.07e-07	0.000164	CbGpPWpGaD
Glimepiride—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.99e-07	0.000116	CbGpPWpGaD
